PSC
DXCM icon

Portman Square Capital’s DexCom DXCM Stock Holding History

Portman Square Capital’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-44,800
Closed -$5.56M – 350
2023
Q4 		$5.56M Sell
44,800
-700
-2% -$71.5K 0.13% 187
2023
Q3 		$4.25M Buy
45,500
+28,000
+160% +$3.16M 0.1% 206
2023
Q2 		$2.25M Buy
+17,500
New +$2.12M 0.06% 229

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Portman Square Capital's DXCM Position: Q1 2024 in Review

Portman Square Capital sold out of DexCom (DXCM) in Q1 2024, closing a stake of 6,988 shares — an estimated $867K sold.

Portman Square Capital first reported a position in DXCM in Q2 2023 and held it in 3 quarters. The position peaked at $4.91M in Q3 2023. 1,032 funds tracked by Wall St. Rank hold DXCM as of Q1 2024.

  • Portman Square Capital reported no remaining DexCom position as of Q1 2024 after selling out during the quarter.
  • Portman Square Capital sold 6,988 DexCom shares in Q1 2024, an estimated $867K.
  • Portman Square Capital first reported a position in DexCom in Q2 2023 and held it in 3 quarters.
  • Portman Square Capital's DexCom position peaked at $4.91M in Q3 2023.
  • 1,032 funds tracked by Wall St. Rank held DexCom as of Q1 2024.

Based on Portman Square Capital's 13F filing for Q1 2024, filed 15 Apr 2024.